Use of methotrexate in patients with uveitis

CER4007
2010 Vol.28, N°5 ,Suppl.61
PI 0145, PF 0150
Review

Free to view
(click on article PDF icon to read the article)

PMID: 21044449 [PubMed]

Received: 22/07/2010
Accepted : 03/09/2010
In Press: 28/10/2010
Published: 28/10/2010

Abstract

Methotrexate has been frequently employed to treat ocular inflammatory diseases including uveitis, scleritis, and orbital inflammatory disease. It is effective for intraocular lymphoma when given directly into the eye. No study has assessed its efficacy for eye disease in a randomised, placebo controlled design. This report reviews the literature relevant to methotrexate`s utility in the treatment of ocular inflammatory disease.